Training Urologists To Be Experts In Renal Cell Carcinoma
Christopher G. Wood, M. D., FACS Professor and Deputy Chairman Douglas E. Johnson, M. D. Endowed Professorship In Urology Department of Urology The University of Texas MD Anderson Cancer Center outlin...
Author: kidneycancer
Added: 11/08/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 9, 2017 Category: Cancer & Oncology Source Type: podcasts
2017 Nizar M Tannir, MD - Eugene P. Schonfeld Memorial Lecture
Nizar M. Tannir, MD Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston accepts the 2017 Kidney Cancer Asso...
Author: kidneycancer
Added: 11/06/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 6, 2017 Category: Cancer & Oncology Source Type: podcasts
What Other Options Are Available for Patients Resistant to Ibrutinib?
What additional CLL treatment options are available for patients who develop resistance to ibrutinib (Imbruvica)? Dr. Michael Keating, a leading CLL expert from The University of Texas MD Anderson Can...
Author: patientpower
Added: 10/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Exercising Despite MPN-Related Fatigue
Many MPN patients experience fatigue and, although it seems counter-intuitive, exercising actually helps to improve energy levels. Dr. Naveen Pemmaraju from The University of Texas MD Anderson Cancer ...
Author: patientpower
Added: 09/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - September 30, 2017 Category: Cancer & Oncology Source Type: podcasts
Does Risk of Progression Increase If Essential Thrombocythemia (ET) Is Untreated?
In this Ask the Expert segment featuring Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center, a Patient Power community member wants to know if the rate of progression is incre...
Author: patientpower
Added: 07/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 19, 2017 Category: Cancer & Oncology Source Type: podcasts
Are There MPN Treatments That Reduce Fibrosis and Slow Disease Progression?
In this Ask the Expert segment, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center responds to MPN community member, Susan. Susan asks if there are MPN treatments that reduce ...
Author: P2Professional
Added: 07/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 7, 2017 Category: Cancer & Oncology Source Type: podcasts
Are There MPN Treatments That Reduce Fibrosis and Slow Disease Progression?
In this Ask the Expert segment, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center responds to MPN community member, Susan. Susan asks if there are MPN treatments that reduce ...
Author: patientpower
Added: 07/07/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 7, 2017 Category: Cancer & Oncology Source Type: podcasts
MPN News and Updates From ASCO 2017
As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for pa...
Author: patientpower
Added: 06/13/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 14, 2017 Category: Cancer & Oncology Source Type: podcasts
Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study @KidneyCancer
Hans J. Hammers, MD of the University of Texas Southwestern Medical Center discusses Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma...
Author: kidneycancer
Added: 04/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 25, 2017 Category: Cancer & Oncology Source Type: podcasts
What Does Molecular Remission Mean for MPN Patients?
What is molecular remission in MPNs, and how is it achieved? As part of our MPN Ask the Expert series, Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds by explaining...
Author: P2Professional
Added: 04/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2017 Category: Cancer & Oncology Source Type: podcasts
What Does Molecular Remission Mean for MPN Patients?
What is molecular remission in MPNs, and how is it achieved? As part of our MPN Ask the Expert series, Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds by explaining...
Author: patientpower
Added: 04/14/2017 (Source: Oncology Tube)
Source: Oncology Tube - April 15, 2017 Category: Cancer & Oncology Source Type: podcasts
What Does a Bone Marrow Biopsy Tell Us About Your MPN?
MPN experts, Dr. Michael Grunwald from Carolinas HealthCare System's Levine Cancer Institute and Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center, share insights on the purp...
Author: P2Professional
Added: 03/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2017 Category: Cancer & Oncology Source Type: podcasts
What Does a Bone Marrow Biopsy Tell Us About Your MPN?
MPN experts, Dr. Michael Grunwald from Carolinas HealthCare System's Levine Cancer Institute and Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center, share insights on the purp...
Author: patientpower
Added: 03/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 16, 2017 Category: Cancer & Oncology Source Type: podcasts
Combined treatment with BRAF and MEK inhibitors in metastatic melanomas with BRAF mutations
Rodabe N. Amaria, MD from the University of Texas MD Anderson Cancer Center, Houston, TX gives an overview on the benefits of combined treatment with BRAF and MEK inhibitors for metastatic melanoma at...
Author: VJOncology
Added: 02/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 21, 2017 Category: Cancer & Oncology Source Type: podcasts
Neoadjuvant therapy with trametinib and dabrafenib in high risk resectable BRAF-mutant melanoma
Rodabe N. Amaria, MD from the University of Texas MD Anderson Cancer Center, Houston, TX summarizes results on a recent randomized Phase II clinical trial of neoadjuvant treatment with BRAF and MEK in...
Author: VJOncology
Added: 02/16/2017 (Source: Oncology Tube)
Source: Oncology Tube - February 16, 2017 Category: Cancer & Oncology Source Type: podcasts
